Prothrombotic state in HIV: A study on protein C, protein S, homocysteine and correlation with CD4 counts

Introduction: Human immunodeficiency virus (HIV) may result in variable haematological manifestations. Thrombotic events are more common among HIV-infected persons than the general population, possibly due to the increased inflammatory/hypercoagulable state and presence of concurrent comorbidities. Aims and Objectives: (1) Screen for coagulation abnormalities in HIV-infected patients. (2) Detect certain prothrombotic factors such as deficiency of protein C and protein S and elevation of homocysteine as possible precursors of coagulation defects in HIV patients. (3) Correlation of coagulation abnormalities with CD4 counts. Methods: A pilot study of 1-year duration conducted in the Department of Pathology in collaboration with ART centre, KGMU Lucknow. All diagnosed HIV-seropositive patients (n = 30) who were not taking Vitamin K, antithrombotic and antiplatelet drugs including aspirin, oral contraceptives and not having known protein C/S deficiency were included in the present study as cases. Apart from this, 30 age- and sex-matched healthy individuals were also included in the present study. Assessment of the bleeding time, prothrombin time and activated partial thromboplastin time, complete blood count was done. Protein C and S were measured by calorimetric assay. Serum homocysteine was measured by the semi-automated method. CD4 count was done by flow cytometry. Results: The findings of the present study suggest a relationship between HIV, its complications and thrombosis. The HIV-seropositive patients have reduced levels of haemoglobin, CD4 counts, platelet counts, mean platelet volume, protein C and S activity as compared to the healthy individuals. Thrombophilic abnormality in the form of hyperhomocysteinaemia is more frequent in HIV-infected patients. All these parameters have a definite correlation with CD4 count.

[1]  M. Atadzhanov,et al.  HIV infection, hypercoagulability and ischaemic stroke in adults at the University Teaching Hospital in Zambia: a case control study , 2017, BMC Infectious Diseases.

[2]  A. Abdollahi,et al.  Hyperhomocysteinemia in HIV-Infected Individuals: Correlation of a Frequent Prothrombotic Factor with CD4+ Cell Count. , 2012, Oman medical journal.

[3]  Á. Castro,et al.  HIV Increases Mean Platelet Volume During Asymptomatic HIV Infection in Treatment-Naive Patients , 2011, Journal of acquired immune deficiency syndromes.

[4]  A. Antinori,et al.  Mediterranean Journal of Hematology and Infectious Diseases Hiv-associated Venous Thromboembolism , 2011 .

[5]  R. Omoregie,et al.  Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria. , 2009, The West Indian medical journal.

[6]  A. Velayati,et al.  Anemia Prevalence And Related Factors In HIV-Infected Patients: A Cohort Study , 2008 .

[7]  M. Vekemans,et al.  PORTAL VEIN THROMBOSIS IN A PATIENT WITH HIV TREATED WITH A PROTEASE INHIBITOR-CONTAINING REGIMEN , 2006, Acta clinica Belgica.

[8]  H. ten Cate,et al.  Is chronic HIV infection associated with venous thrombotic disease? A systematic review. , 2005, The Netherlands journal of medicine.

[9]  E. Frenkel,et al.  Thrombosis and a Hypercoagulable State in HIV-Infected Patients , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[10]  A. Justice,et al.  Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. , 2004, The American journal of medicine.

[11]  A. Majluf-Cruz,et al.  Venous Thrombosis Among Patients with AIDS , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[12]  V. Rickerts,et al.  Acquired Protein C and Protein S Deficiency in HIV-Infected Patients , 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[13]  V. Venkatesh,et al.  A pilot study on observations on CD4 & CD8 counts in healthy HIV seronegative individuals. , 2002, The Indian journal of medical research.

[14]  M. Cattaneo Hyperhomocysteinemia, Atherosclerosis and Thrombosis , 1999, Thrombosis and Haemostasis.

[15]  J. Church,et al.  Acquired protein S deficiency in children infected with human immunodeficiency virus. , 1996, The Pediatric infectious disease journal.

[16]  R. Marlar,et al.  Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  M. Ranieri,et al.  Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies. , 1994, Thrombosis research.

[18]  W. Borkowsky,et al.  Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. , 1993, Blood.

[19]  M. Saif,et al.  HIV and thrombosis: a review. , 2001, AIDS patient care and STDs.